Luye Pharma Group Ltd. (HKG:2186)
Hong Kong
· Delayed Price · Currency is HKD 1.970
+0.020 (1.03%)
May 12, 2025, 4:08 PM HKT
Luye Pharma Group Revenue
In the year 2024, Luye Pharma Group had annual revenue of 6.06B CNY, down -1.33%. Luye Pharma Group had revenue of 2.99B in the half year ending December 31, 2024, a decrease of -4.60%.
Revenue
6.06B CNY
Revenue Growth
-1.33%
P/S Ratio
1.15
Revenue / Employee
1.18M CNY
Employees
5,150
Market Cap
7.41B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.06B | -81.64M | -1.33% |
| Dec 31, 2023 | 6.14B | 161.42M | 2.70% |
| Dec 31, 2022 | 5.98B | 781.43M | 15.03% |
| Dec 31, 2021 | 5.20B | -339.42M | -6.13% |
| Dec 31, 2020 | 5.54B | -818.21M | -12.87% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Alibaba Health Information Technology | 31.39B |
| Akeso | 2.26B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |
Luye Pharma Group News
- 7 months ago - RRJ Buys $150 Million Luye Bonds, First China Deal Since 2019 - BNN Bloomberg